Helicobacter pylori infection and surgical disease - Part II

Current Problems in Surgery

Volumn 42, Issue 12, 2005, Pages 804-862

  Stabile, Bruce E ^a   Smith, Brian R ^b   Weeks, David L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ASCORBIC ACID; BACTERIAL PROTEIN; BETA CAROTENE; CAGA PROTEIN; HELICOBACTER PYLORI VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; PROTEIN P53; PROTON PUMP INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VACUOLATING TOXIN;

ALCOHOL CONSUMPTION; ANTIBIOTIC RESISTANCE; ASPIRATION BIOPSY; BACTERIAL GENE; BACTERIAL VIRULENCE; BALLOON DILATATION; BARRETT ESOPHAGUS; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; DIARRHEA; DISEASE ASSOCIATION; DNA POLYMORPHISM; DUODENUM ULCER; DYSPEPSIA; ENDOSCOPIC ECHOGRAPHY; ERADICATION THERAPY; ESOPHAGITIS; ESOPHAGUS CANCER; FAMILIAL DISEASE; GASTRECTOMY; GASTRITIS; GASTRODUODENOSTOMY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROJEJUNOSTOMY; GASTROSCOPY; GENE CLUSTER; GENE MUTATION; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTERMETHOD COMPARISON; INTRACTABLE PAIN; LAPAROSCOPY; METAPLASIA; MORBIDITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; NUTRITIONAL SUPPORT; PATIENT COMPLIANCE; PEPTIC ULCER; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; PREVALENCE; PYLOROPLASTY; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; STOMACH ADENOCARCINOMA; STOMACH ANTRUM RESECTION; STOMACH CANCER; STOMACH OBSTRUCTION; STOMACH ULCER; SURGICAL APPROACH; SURGICAL DRAINAGE; SURGICAL MORTALITY; SURVIVAL TIME; T LYMPHOCYTE; TRUNCUS VAGOTOMY; ULCER PERFORATION; ULCEROGENESIS; VITAMIN SUPPLEMENTATION; ABDOMINAL SURGERY; GASTROINTESTINAL DISEASE; MICROBIOLOGY; PATHOGENICITY;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 29744453934     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2005.08.010     Document Type: Note

References (260)

1. C.S. Goodwin J.A. Armstrong B.J. Marshall et al. Campylobacter pyloridis, gastritis, and peptic ulceration J Clin Pathol 39 1986 353-365
2. + Helicobacter pylori strains Lab Invest 73 1995 760-770
3. A.T. Axon Are all Helicobacters equal? Mechanisms of Gastroduodenal pathology and their clinical implications Gut 45 Suppl 1 1999 I1-I4
4. T. Tomita A.M. Jackson N. Hida M. Hayat M.F. Dixon T. Shimoyama et al. Expression of interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection J Infect Dis 167 2001 926-934
5. C. Nilsson A. Sillen L. Eriksson M.L. Strand H. Enroth S. Normark et al. Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease Infect Immun 71 2003 6573-6581
6. S. Miehlke A. Hackelsberger G. Meining R. Hatz N. Lehn P. Malfertheiner et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori Br J Cancer 78 1998 263-266
7. A.C. Wootherspoon C. Ortiz-Hidalgo M.R. Falzon P.G. Isaacson et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma Lancet 338 1991 1175-1176
8. J. Parsonnet S. Hansen L. Rodriguez A.B. Gelb R.A. Warnke E. Jellum et al. Helicobacter pylori infection and gastric lymphoma N Engl J Med 330 1994 1267-1271
9. T. Hussell P.G. Isaacson J.E. Crabtree J. Spencer et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori Lancet 342 1993 571-574
10. N.J. Talley A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia Gastroenterology 106 1994 1174-1183
11. A.L. Blum N.J. Talley C. O'Morain S.V. van Zanten J. Labenz M. Stolte et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus clarithromycin and amoxicillin effect one year after treatment (OCAY) study group. N Engl J Med 339 1998 1875-1881
12. N.J. Talley N. Vakil E.D. Ballard 2nd M.B. Fennerty Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia N Engl J Med 341 1999 1106-1111
13. G.N. Tytgat L.A. Noach E.A. Rauws Helicobacter pylori infection and duodenal ulcer disease Gastroenterol Clin North Am 22 1993 127-139
14. I. Raiha H. Kemppainen J. Kaprio M. Koskenvuo L. Sourander Lifestyle, stress, and genes in peptic ulcer disease a nationwide twin cohort study Arch Intern Med 158 1998 698-704
15. C.W. Howden R.H. Hunt Guidelines for the management of Helicobacter pylori infection. Ad hoc committee on practice parameters of the American College of Gastroenterology Am J Gastroenterol 93 1998 2330-2338
16. S. Rosenstock T. Jorgensen O. Bonnevie L. Anderson Risk factors for peptic ulcer disease a population based prospective cohort study comprising 2416 Danish adults Gut 52 2003 186-193
17. A. Nomura G.N. Stemmermann P.H. Chyou G.I. Perez-Perez M.J. Blaser Helicobacter pylori infection and the risk for duodenal and gastric ulceration Ann Intern Med 120 1994 977-981
18. D.Y. Graham G.M. Lew P.D. Klein D.G. Evans D.J. Evans Jr Z.A. Saeed et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study Ann Intern Med 116 1992 705-708
19. R.J. Hopkins L.S. Girardi E.A. Turney et al. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review Gastroenterology 110 1996 1244-1252
20. R.W. Van der Hulst E.A. Rauws B. Koycu J.J. Keller M.J. Bruno J.G. Tijssen et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study Gastroenterology 113 1997 1082-1086
21. H. Cohen Peptic ulcer and Helicobacter pylori Gastroenterol Clin North Am 29 2000 775-789
22. K.D. Bardhan D.Y. Graham R.H. Hunt C.A. O'Morain et al. Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole Helicobacter 2 1997 27-31
23. J.E. Crabtree J.D. Taylor J.I. Wyatt R.V. Heatley T.M. Shallcross D.S. Tompkins et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology Lancet 338 1991 332-335
24. A. Covacci S. Censini M. Bugnoli R. Petracca D. Burroni G. Macchia et al. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer Proc Natl Acad Sci USA 90 1993 5791-5795
25. E. el-Omar I. Penman C.A. Dorrian J.E. Ardill K.E. McColl et al. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer Gut 34 1993 1060-1065
26. E.M. el-Omar I.D. Penman J.E. Ardill R.S. Chittajallu C. Howie K.E. McColl Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease Gastroenterology 109 1995 681-689
27. H.C. Weber D.J. Venzon R.T. Jensen D.C. Metz Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy Gastroenterology 112 1997 84-91
28. G.L. Kauffman Jr. Duodenal ulcer disease treatment by surgery, antibiotics, or both Adv Surg 34 2000 121-135
29. J.I. Wyatt B.J. Rathbone G.M. Sobala T. Shallcross R.V. Heatley A.T. Axon et al. Gastric epithelium in the duodenum its association with Helicobacter pylori and inflammation J Clin Pathol 43 1990 981-986
30. D.L. Hogan R.C. Rapier A. Dreilinger M.A. Koss P.M. Basuk W.M. Weinstein et al. Duodenal bicarbonate secretion eradication of Helicobacter pylori and duodenal structure and function in humans Gastroenterology 110 1996 705-716
31. J. Carrick A. Lee S. Hazell M. Ralston G. Daskalopoulos Campylobacter pylori, duodenal ulcer, and gastric metaplasia possible role of functional heterotopic tissue in ulcerogenesis Gut 30 1989 790-797
32. S. Niemela J. Heikkila J. Lehtola Duodenogastric bile reflux in patients with gastric ulcer Scand J Gastroenterol 19 1984 896-898
33. H.D. Johnson Gastric ulcer: Classification, blood group characteristics, secretion patterns and pathogenesis Ann Surg 162 1965 996-1004
34. L.H. Lickstein J.B. Mathews Elective surgical management of peptic ulcer disease Prob Gen Surg 14 1997 37-53
35. F.L. Lanza A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs Scand J Gastroenterol Suppl 163 1989 24-31
36. L. Laine S. Harper T. Simon R. Bath J. Johanson H. Schwartz et al. Rofecoxib A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Osteoarthritis Endoscopy Study Group Gastroenterology 117 1999 776-783
37. L.S. Simon A.L. Weaver D.Y. Graham A.J. Kivitz P.E. Lipsky R.C. Hubbard et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial JAMA 282 1999 1921-1928
38. C. Hawkey L. Laine T. Simon A. Beaulieu J. Maldonado-Cocco E. Acevedo et al. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group. Arthritis Rheum 43 2000 370-377
39. L. Laine Nonsteroidal anti-inflammatory drug gastropathy Gastrointest Endosc Clin N Am 6 1996 489-504
40. G. Singh D. Rosen Ramey NSAID induced gastrointestinal complications the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System J Rheumatol Suppl1 51 1998 8-16
41. M.H. Chen M.S. Wu W.C. Lee H.P. Wang J.T. Lin A multiple logistic regression analysis of risk factors in different subtypes of gastric ulcer Hepatogastroenterology 49 2002 589-592
42. V. Isakov P. Malfertheiner Helicobacter pylori and nonmalignant diseases Helicobacter 8 Suppl 1 2003 36-43
43. J. Labenz A.L. Blum W.W. Bolten B. Dragosics W. Rosch M. Stolte et al. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients a randomized, double blind, placebo controlled, clinical trial Gut 51 2002 329-335 335
44. K.C. Lai C.S. Lau W.Y. Ip B.C. Wong W.M. Hui W.H. Hu et al. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: A double-blind, placebo-controlled trial Aliment Pharmacol Ther 17 2003 799-805 805
45. H. Miwa N. Sakaki K. Sugano H. Sekine K. Higuchi N. Uemura et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: A multicenter study of 4940 patients Helicobacter 9 2004 9-16
46. M. Hojo H. Miwa A. Nagahara N. Sato Pooled analysis of the efficacy of the second-line treatment regimens for Helicobacter pylori infection Scand J Gastroenterol 36 2001 690-700
47. B.E. Stabile Current surgical management of duodenal ulcers Surg Clin North Am 72 1992 335-356
48. D. Johnston R.L. Blackett A new look at selective vagotomies Am J Surg 156 1988 416-427
49. B.D. Schirmer Current status of proximal gastric vagotomy Ann Surg 209 1989 131-148
50. N.J. Soper K.A. Kelly J.A. van Heerden D.M. Ilstrup Long term clinical results after proximal gastric vagotomy Surg Gynecol Obstet 169 1989 488-494
51. P.H. Jordan Jr J. Thornby Twenty years after parietal cell vagotomy or selective vagotomy antrectromy for treatment of duodenal ulcer. Final report Ann Surg 220 1994 283-293
52. S. Meisner L.N. Jorgensen H.E. Jensen The Kaplan and Meier and the Nelson estimate for the probability of ulcer recurrence 10 and 15 years after parietal cell vagotomy Ann Surg 207 1988 1-3
53. N. Katkhouda J. Mouiel A new technique of surgical treatment of chronic duodenal ulcer without laparotomy by videocoelioscopy Am J Surg 161 1991 361-364
54. F. Dubois New surgical strategy for gastroduodenal ulcer: Laparoscopic approach World J Surg 24 2000 270-276 276
55. P.E. Dohahue H.M. Richter K.J. Liu K. Anan L.M. Nyhus Experimental basis and clinical application of extended highly selective vagotomy for duodenal ulcer Surg Gynecol Obstet 176 1993 39-48
56. P.E. Donahue Parietal cell vagotomy versus vagotomy-antrectomy: Ulcer surgery in the modern era World J Surg 24 2000 264-269
57. G.G. Jamieson Current status of indications for surgery in peptic ulcer disease World J Surg 24 2000 256-258
58. P.H. Jordan Jr. Surgery for peptic ulcer disease Curr Prob Surg 28 1991 265-330
59. P. Madsen P. Schousen Long term results of truncal vagotomy and pyloroplasty for gastric ulcer Br J Surg 69 1982 651-654
60. P.H. Jordan Jr. Indications for parietal cell vagotomy without drainage in gastrointestinal surgery Ann Surg 210 1989 29-41
61. D.A. Reid H.L. Duthie C.J. Bransom A.G. Johnson Late follow-up of highly selective vagotomy with excision of the ulcer compared with Billroth I Gastrectomy for treatment of benign gastric ulcer Br J Surg 69 1982 605-607
62. P.H. Jordan Jr. Type I gastric ulcer treated by parietal cell vagotomy and mucosal ulcerectomy J Am Coll Surg 182 1996 388-393
63. J.W. Hollinshead R.C. Smith D.J. Gillett Parietal cell vagotomy: experience with 114 patients with prepyloric or duodenal ulcer World J Surg 6 1982 596-602
64. B. Poppen A. Delin Parietal cell vagotomy for duodenal and pyloric ulcers. Clinical factors leading to failure of the operation Am J Surg 141 1981 323-329
65. G. Heberer R.K. Teichmann Recurrence after proximal gastric vagotomy for gastric, pyloric, and prepyloric ulcers World J Surg 11 1987 283-288
66. D.V. Feliciano Do perforated duodenal ulcers need an acid-decreasing surgical procedure now that omeprazole is available? Surg Clin North Am 72 1992 369-380
67. M.P. McDonald T.A. Broughan R.E. Hermann R.S. Philip S.O. Hoerr Operations for gastric ulcer: A long-term study Am Surg 62 1996 673-677
68. D.H. Reinbach G. Cruickshank K.E. McColl Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection Gut 34 1993 1344-1347
69. M. Sebastian V.P. Chandran Y.I. Elashaal A.J. Sim Helicobacter pylori infection in perforated peptic ulcer disease Br J Surg 82 1995 360-362
70. D.W. Bliss B.E. Stabile The impact of ulcerogenic drugs on surgery for the treatment of peptic ulcer disease Arch Surg 126 1991 609-612
71. J. Boey S.K. Choi A. Poon T.T. Alagaratnam Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors Ann Surg 205 1987 22-26
72. G.E. Griffin C.H. Organ Jr. The natural history of the perforated duodenal ulcer treated by suture placation Ann Surg 183 1976 382-385
73. J. Boey J. Wong Perforated duodenal ulcers World J Surg 11 1987 319-324
74. P.C. Bornman N.A. Theodorou P.C. Jeffery I.N. Marks H.P. Essel J.P. Writght et al. Simple closure of perforated duodenal ulcer: A prospective evaluation of a conservative management policy Br J Surg 77 1990 73-75
75. J. Boey N.W. Lee J. Koo P.H. Lam J. Wong G.B. Ong Immediate definitive surgery for perforated duodenal ulcers: A prospective controlled trial Ann Surg 196 1982 338-344
76. J. Christiansen O.B. Andersen T. Bonnesen N. Baeckgaard Perforated duodenal ulcer managed by simple closure versus closure and proximal gastric vagotomy Br J Surg 74 1987 286-287
77. J.M. Hay F. Lacaine G. Kohlmann A. Fingerhut Immediate definitive surgery for perforated duodenal ulcer does not increase operative mortality: A prospective controlled trial World J Surg 12 1988 705-709 709
78. C. Tanphiphat T. Tanprayoon A. Na Thalang Surgical treatment of perforated duodenal ulcer: A prospective trial between simple closure and definitive surgery Br J Surg 72 1985 370-372
79. W.Y. Lau K.L. Leung K.H. Kwong I.C. Davey C. Robertson J.J. Dawson et al. A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique Ann Surg 224 1996 131-138
80. B.E. Stabile Redefining the role of surgery for perforated duodenal ulcer in the Helicobacter pylori era Ann Surg 231 2000 159-160
81. E.K. Ng Y.H. Lam J.J. Sung M.Y. Yung K.F. To A.C. Chan et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: Randomized controlled trial Ann Surg 231 2000 153-158
82. V. Kate N. Ananthakrishnan S. Badrinath Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: Retrospective and prospective randomized controlled studies Br J Surg 88 2001 1054-1058
83. B.E. Stabile H.J. Hardy E. Passaro Jr. "Kissing" duodenal ulcers Arch Surg 114 1979 1153-1156
84. T.J. Crofts K.G. Park R.J. Steele S.S. Chung A.K. Li A randomized trial of nonoperative treatment for perforated peptic ulcer N Engl J Med 320 1989 970-973
85. T.V. Berne A.J. Donovan Nonoperative treatment of perforated duodenal ulcer Arch Surg 124 1989 830-832
86. C. Marshall P. Ramaswamy F.G. Bergin I.L. Rosenberg D.J. Leaper Evaluation of a protocol for the non-operative management of perforated peptic ulcer Br J Surg 86 1999 131-134
87. B.E. Stabile E. Passaro Jr. Surgery for duodenal and gastric ulcer disease Adv Surg 26 1993 275-306
88. C. Steffes D. Fromm The current diagnosis and management of upper gastrointestinal bleeding Adv Surg 25 1992 331-361
89. C. Sugawa C.P. Steffes R. Nakamura J.J. Sferra C.S. Sferra Y. Sugimura et al. Upper GI bleeding in an urban hospital. Etiology, recurrence, and prognosis Ann Surg 212 1990 521-526
90. F.J. Branicki J. Boey P.J. Fok C.J. Pritchett S.T. Fan E.C. Lai et al. Bleeding duodenal ulcer. A prospective evaluation of risk factors for rebleeding and death Ann Surg 211 1990 411-418
91. G. Hasselgren J. Carlsson T. Lind O. Schaffalitzky de Muckadell L. Lundell Risk factors for rebleeding and fatal outcome in elderly patients with acute peptic ulcer bleeding Eur J Gastroenterol Hepatol 10 1998 667-672
92. P. Wara Endoscopic prediction of major rebleeding-a prospective study of stigmata of hemorrhage in bleeding ulcer Gastroenterology 88 1985 1209-1214
93. D.J. Cook G.H. Guyatt B.J. Salena L.A. Laine Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis Gastroenterology 102 1992 139-148
94. H.S. Sachs T.C. Chalmers A.L. Blum J. Berrier D. Pagano Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers JAMA 264 1990 494-499
95. W.L. Peterson D.J. Cook Antisecretory therapy for bleeding peptic ulcer JAMA 280 1998 877-878
96. M.S. Khuroo G.N. Yattoo G. Javid B.A. Khan A.A. Shah G.M. Gulzar et al. A comparison of omeprazole and placebo for bleeding peptic ulcer N Engl J Med 336 1997 1054-1058
97. H.J. Lin W.C. Lo F.Y. Lee C.L. Perng G.Y. Tseng A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy Arch Intern Med 158 1998 54-58
98. J.A. Hamlin B. Petersen F.S. Keller J. Rosch Angiographic evaluation and management of nonvariceal upper gastrointestinal bleeding Gastrointest Endosc Clin N Am 7 1997 703-716
99. A.M. Kapetanakis E.P. Kyprizlis T.S. Tsikrikas Efficacy of repeated therapeutic endoscopy in patients with bleeding ulcer Hepatogastroenterology 44 1997 288-293
100. J.Y. Lau J.J. Sung Y.H. Lam A.C. Chan E.K. Ng D.W. Lee et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers N Engl J Med 340 1999 751-756
101. L. Laine W.L. Peterson Bleeding peptic ulcer N Engl J Med 331 1994 717-727
102. T.A. Rockall Management and outcome of patients undergoing surgery after acute upper gastrointestinal haemorrhage. Steering Group for the National Audit of Acute Upper Gastrointestinal Haemorrhage J R Soc Med 91 1998 518-523
103. B. Millat A. Fingerhut F. Borie Surgical treatment of complicated duodenal ulcers: Controlled trials World J Surg 24 2000 299-306
104. B.E. Stabile M.J. Stamos Surgical management of gastrointestinal bleeding Gastroenterol Clin North Am 29 2000 189-222
105. L.T. Palumbo W.S. Sharpe Active bleeding duodenal ulcer. Management during ten-year period Surg Clin North Am 47 1967 239-254
106. B.E. Stabile Surgical treatment of peptic ulceration Curr Opin Gen Surg 1 1993 206-215
107. Y. Tokunaga K. Hata J. Ryo A. Kitaoka A. Tokuka K. Ohsumi Density of Helicobacter pylori infection in patients with peptic ulcer perforation J Am Coll Surg 186 1998 659-663
108. A.E. Henriksson A.C. Edman I. Nilsson D. Bergqvist T. Wadstrom Helicobacter pylori and the relation to other risk factors in patients with acute bleeding peptic ulcer Scand J Gastroenterol 33 1998 1030-1033
109. D. Jaspersen T. Koerner W. Schorr M. Brennenstuhl C. Raschka C.H. Hammar Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage Gastrointest Endosc 41 1995 5-7
110. T. Rokkas A. Karameris A. Mavrogeorgis E. Rallis N. Giannikos Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease Gastrointest Endosc 41 1995 1-4
111. C. Aalykke J.M. Lauritsen J. Hallas S. Reinholdt K. Krogfelt K. Lauritsen Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study Gastroenterology 116 1999 1305-1309
112. J. Lee C. O'Morain Who should be treated for Helicobacter pylori infection? A review of consensus conferences and guidelines Gastroenterology 113 1997 S99-S106
113. C.S. Chung Surgery and gastrointestinal bleeding Gastrointest Endosc Clin N Am 7 1997 687-701
114. J.T. Makela H. Kiviniemi S. Laitinen Gastric outlet obstruction caused by peptic ulcer disease analysis of 99 patients Hepatogastroenterology 43 1996 547-552
115. S.K. Khullar J.A. DiSario Gastric outlet obstruction Gastrointest Endosc Clin N Am 6 1996 585-603
116. S.O. Hoerr J.T. Ward Late results of three operations for chronic duodenal ulcer: Vagotomy-gastrojejunostomy, vagotomy-hemigastrectomy, vagotomy-pyloroplasty. Interim report Ann Surg 176 1972 403-411
117. B.E. Stabile E. Passaro Jr. Duodenal ulcer: A disease in evolution Curr Prob Surg 21 1984 1-79
118. J.B. Gibson S.W. Behrman T.C. Fabian L.G. Britt Gastric outlet obstruction resulting from peptic ulcer disease requiring surgical intervention is infrequently associated with Helicobacter pylori infection J Am Coll Surg 191 2000 32-37
119. J.J. Boylan M.I. Gradzka Long-term results of endoscopic balloon dilatation for gastric outlet obstruction Dig Dis Sci 44 1999 1883-1886
120. Y. Lam J.Y. Lau K.B. Law J.J. Sung S.S. Chung Endoscopic balloon dilation and Helicobacter pylori eradication in the treatment of gastric outlet obstruction Gastointest Endosc 46 1997 379-380
121. A. Raghunath A.P. Hungin D. Wooff S. Childs Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: Systematic review BMJ 326 2003
122. G. Manes O. Pieramico G. Uomo S. Mosca C. de Nucci A. Balzano Relationship of sliding hiatus hernia to gastroesophageal reflux disease: A possible role for Helicobacter pylori infection? Dig Dis Sci 48 2003 303-307
123. L. Laine J. Sugg Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: A post hoc analysis of eight double blind prospective studies Am J Gastroenterol 97 2002 2992-2997
124. P. Malfertheiner J. Dent L. Zeijlon P. Sipponen S.J. Veldhuyzen Van Zanten C.R. Burman Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease-results from a randomized trial programme Aliment Pharmacol Ther 16 2002 1431-1442
125. H. Miwa Y. Sugiyama T. Ohkusa A. Kurosawa M. Hojo T. Yokoyama et al. Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: A case-controlled study in the Japanese population Helicobacter 7 2002 219-224 224
126. W. Schwizer M. Thumshirn J. Dent I. Guldenschuh D. Menne G. Cathomas et al. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: A randomized controlled trial Lancet 357 2001 1738-1742
127. J.E. Pandolfino C.W. Howden P.J. Kahrilas H. pylori and GERD: Is less more? Am J Gastroenterol 99 2004 1222-1225
128. H.B. El-Serag A. Sonnenberg M.M. Jamal J.M. Inadomi L.A. Crooks R.M. Feddersen Corpus gastritis is protective against reflux oesophagitis Gut 45 1999 181-185
129. Y. Abe S. Ohara T. Koike H. Sekine K. Iijima M. Kawamura et al. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan Am J Gastroenterol 99 2004 1213-1221
130. A.P. Weston A.S. Badr M. Topalovski R. Cherian A. Dixon R.S. Hassanein Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma Am J Gastroenterol 95 2000 387-394
131. W.H. Chow M.J. Blaser W.J. Blot M.D. Gammon T.L. Vaughan H.A. Risch et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma Cancer Res 58 1998 588-590
132. D.Y. Graham The changing epidemiology of GERD: Geography and Helicobacter pylori Am J Gastroenterol 98 2003 1462-1470
133. N.B. Vakil Review: Article gastro-oesophageal reflux disease and Helicobacter pylori infection Aliment Pharmacol Ther 16 Suppl 1 2002 47-51
134. J. Labenz A.L. Blum E. Bayerdorffer A. Meining M. Stolte G. Borsch Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis Gastroenterology 112 1997 1442-1447
135. C.S. Fuchs R.J. Mayer Gastric carcinoma N Engl J Med 333 1995 32-41
136. P. Lauren The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31-49
137. P. Correa Human gastric carcinogenesis: A multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention Cancer Res 52 1992 6735-6740
138. T. Hattori Development of adenocarcinomas in the stomach Cancer 57 1986 1528-1534
139. M. Bamba H. Sugihara R. Kushima K. Okada S. Tsukashita M. Horinouchi et al. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach Virchows Arch 438 2001 49-56
140. C. Imrie M. Rowland B. Bourke B. Drumm Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 107 2001 373-380
141. C.A. Gonzalez N. Sala G. Capella Genetic susceptibility and gastric cancer risk Int J Cancer 100 2002 249-260
142. E.M. el-Omar M. Carrington W.H. Chow K.E. McColl J.H. Bream H.A. Young et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 2000 398-402
143. J.C. Machado C. Figueiredo P. Canedo P. Pharoah R. Carvalho S. Nabais et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma Gastroenterology 125 2003 364-371
144. E.M. El-Omar C.S. Rabkin M.D. Gammon T.L. Vaughan H.A. Risch J.B. Schoenberg et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms Gastroenterology 124 2003 1193-1201
145. G. Nardone A. Morgner Helicobacter pylori and gastric malignancies Helicobacter 8 Suppl 1 2003 44-52
146. C.M. Fenoglio-Preiser J. Wang G.N. Stemmermann A. Noffsinger TP53 and gastric carcinoma: A review Hum Mutat 21 2003 258-270 270
147. J. Lan Y.Y. Xiong Y.X. Lin B.C. Wang L.L. Gong H.S. Xu et al. Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation World J Gastroenterol 9 2003 54-58
148. C. Morgan G.J. Jenkins T. Ashton A.P. Griffiths J.N. Baxter E.M. Parry et al. Detection of p53 mutations in precancerous gastric tissue Br J Cancer 89 2003 1314-1319
149. C. La Vecchia E. Negri S. Franceschi A. Gentile Family history and the risk of stomach and colorectal cancer Cancer 70 1992 50-55
150. N. Uemura S. Okamoto S. Yamamoto N. Matsumura S. Yamaguchi M. Yamakido et al. Helicobacter pylori infection and the development of gastric cancer N Engl J Med 345 2001 784-789
151. H. Tabata T. Fuchigami H. Kobayashi Y. Sakai M. Nakanishi K. Tomioka et al. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: A special study regarding the methods for detecting Helicobacter pylori Dig Dis Sci 44 1999 2027-2034
152. J.Q. Huang S. Sridhar Y. Chen R.H. Hunt Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer Gastroenterology 114 1998 1169-1179
153. P. Sipponen T.U. Kosunen J. Valle M. Riihela K. Seppala Helicobacter pylori infection and chronic gastritis in gastric cancer J Clin Pathol 45 1992 319-323
154. W.E. Karnes Jr. I.M. Samloff M. Siurala M. Kekki P. Sipponen S.W. Kim et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis Gastroenterology 101 1991 167-174
155. B.C. Wong S.K. Lam W.M. Wong J.S. Chen T.T. Zheng R.E. Feng et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial JAMA 291 2004 187-194
156. C.P. Howson T. Hiyama E.L. Wynder The decline in gastric cancer: epidemiology of an unplanned triumph Epidemiol Rev 8 1986 1-27
157. P. Sipponen Helicobacter pylori infection-a common worldwide environmental risk factor for gastric cancer? Endoscopy 24 1992 424-427
158. P. Sipponen Helicobacter pylori: A cohort phenomenon Am J Surg Pathol 19 Suppl 1 1995 S30-S36
159. H.M. Malaty L. Engstrand N.L. Pedersen D.Y. Graham Helicobacter pylori infection: Genetic and environmental influences. A study of twins Ann Intern Med 120 1994 982-986
160. P.K. Dhillon D.C. Farrow T.L. Vaughan W.H. Chow H.A. Risch M.D. Gammon et al. Family history of cancer and risk of esophageal and gastric cancers in the United States Int J Cancer 93 2001 148-152
161. H.M. Mitchell S.L. Hazell Y.Y. Li P.J. Hu Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country Am J Gastroenterol 91 1996 1785-1788
162. M. Rohde J. Puls R. Buhrdorf W. Fischer R. Haas A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system Mol Microbiol 49 2003 219-234
163. Y. Yamaoka H.M. El-Zimaity O. Gutierrez N. Figura J.G. Kim T. Kodama et al. Relationship between the cagA 3′′′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH Gastroenterology 117 1999 342-349
164. R.M. Peek Jr G.G. Miller K.T. Tham G.U. Perez-Perez X. Zhao J.C. Atherton et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains Lab Invest 73 1995 760-770
165. E.D. Segal J. Cha J. Lo S. Falkow L.S. Tompkins Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori Proc Natl Acad Sci USA 96 1999 14559-14564
166. A. Covacci J.L. Telford G. Del Giudice J. Parsonnet R. Rappuoli Helicobacter pylori virulence and genetic geography Science 284 1999 1328-1333
167. Y. Churin L. Al-Ghoul O. Kepp T.F. Meyer W. Birchmeier M. Naumann Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response J Cell Biol 161 2003 249-255
168. J.Q. Huang G.F. Zheng K. Sumanac E.J. Irvine R.H. Hunt Meta-analysis of the relationship between cagA seropositivity and gastric cancer Gastroenterology 125 2003 1636-1644
169. A. Machida-Montani S. Sasazuki M. Inoue S. Natsukawa K. Shaura Y. Koizumi et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan Gastric Cancer 7 2004 46-53
170. M. Held L. Engstrand L.E. Hansson R. Bergstrom T. Wadstrom O. Nyren Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains? Helicobacter 9 2004 271-277
171. H. Higashi R. Tsutsumi S. Muto T. Sugiyama T. Azuma M. Asaka et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein Science 295 2002 683-686
172. T. Azuma S. Yamazaki A. Yamakawa M. Ohtani A. Muramatsu H. Suto et al. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer J Infect Dis 189 2004 820-827
173. F. Farinati R. Cardin V.M. Russo G. Busatto M. Granco M. Rugge Helicobacter pylori CagA status, mucosal oxidative damage and gastritis phenotype: A potential pathway to cancer? Helicobacter 8 2003 227-234
174. P.Y. Zheng N.L. Jones Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein Cell Microbiol 5 2003 25-40
175. C.F. Zambon F. Navaglia D. Basso M. Rugge M. Plebani Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia J Clin Pathol 56 2003 287-291
176. J.C. Atherton R.M. Peek Jr. K.T. Tham T.L. Cover M.J. Blaser Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112 1997 92-99
177. W.L. Peterson Review article: Helicobacter pylori and gastric adenocarcinoma Aliment Pharmacol Ther 16 Suppl 1 2002 40-46
178. S. Kikuchi Epidemiology of Helicobacter pylori and gastric cancer Gastric Cancer 5 2002 6-15
179. J. Parsonnet D. Forman Helicobacter pylori infection and gastric cancer-for want of more outcomes JAMA 291 2004 244-245
180. Helicobacter and Cancer Collaborative Group Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts Gut 49 2001 347-353 353
181. T. Watanabe M. Tada H. Nagai S. Sasaki M. Nakao Helicobacter pylori infection induces gastric cancer in mongolian gerbils Gastroenterology 115 1998 642-648
182. K. Nozaki N. Shimizu Y. Ikehara M. Inoue T. Tsukamoto K. Inada et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils Cancer Sci 94 2003 235-239
183. J. Ishizuka T. Sugiyama T. Aoyama F. Hirayama M. Tada M. Kato et al. Molecular cloning of p53 cDNA of Mongolian gerbil and establishment of yeast p53 functional assay system Helicobacter 8 2003 81-89
184. J.G. Fox T.C. Wang A.B. Rogers T. Poutahidis Z. Ge N. Taylor et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia Gastroenterology 124 2003
185. J.G. Fox A.B. Rogers M. Ihrig N.S. Taylor M.T. Whary G. Dockray et al. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific Cancer Res 63 2003 942-950
186. G.M. Sobala C.J. Schorah S. Shires D.A. Lynch B. Gallacher M.F. Dixon et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations Gut 34 1993 1038-1041
187. M. Woodward H. Tunstall-Pedoe K. McColl Helicobacter pylori infection reduces systemic availability of dietary vitamin C Eur J Gastroenterol Hepatol 13 2001 233-237
188. P. Correa E.T. Fontham J.C. Bravo L.E. Bravo B. Ruiz G. Zarama et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy J Natl Cancer Inst 92 2000 1881-1888
189. A. Chao M.J. Thun S.J. Henley E.J. Jacobs M.L. McCullough E.E. Calle Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II Int J Cancer 101 2002 380-389
190. S. Sasazuki S. Sasaki Tsugane S; Japan Public Health Center Study Group Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type Int J Cancer 101 2002 560-566
191. M. Nakamura K. Haruma T. Kamada M. Mihara M. Yoshihara M. Sumioka et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects Dig Dis Sci 47 2002 675-681
192. E. Buiatti N. Munoz I. Kato J. Vivas R. Muggli M. Plummer et al. Determinants of plasma anti-oxidant vitamin levels in a population at high risk for stomach cancer Int J Cancer 65 1996 317-322
193. M. Bonacini J.E. Valenzuela Changes in the relative frequency of gastric adenocarcinoma in southern California West J Med 154 1991 172-174
194. L.E. Hansson O. Nyren A.W. Hsing R. Bergstrom S. Josefsson W.H. Chow et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease N Engl J Med 335 1996 242-249
195. C.P. Theuer C. de Virgilio G. Keese S. Grench T. Arnell J. Tolmos et al. Gastric adenocarcinoma in patients 40 years of age or younger Am J Surg 172 1996 473-476
196. J.P. Gupta A.K. Jain B.K. Agrawal S. Gupta Gastroscopic cytology and biopsies in diagnosis of gastric malignancies J Surg Oncol 22 1983 62-64
197. B.J. Pollack A. Chak M.V. Sivak Jr. Endoscopic ultrasonography Semin Oncol 23 1996 336-346
198. G. Caletti A. Ferrari E. Brocchi L. Barbara Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma Surgery 113 1993 14-27
199. K.J. Chang K.D. Katz T.E. Durbin R.A. Erickson J.A. Butler F. Lin et al. Endoscopic ultrasound-guided fine-needle aspiration Gastrointest Endosc 40 1994 694-699
200. D.A. Stell C.R. Carter I. Steward J.R. Anderson Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer Br J Surg 83 1996 1260-1262
201. K.C. Conlon M.S. Karpeh Jr. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer Semin Oncol 23 1996 347-351
202. D.M. Dent M.V. Madden S.K. Price Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma Br J Surg 75 1988 110-112
203. C.S. Robertson S.C. Chung S.D. Woods S.M. Griffin S.A. Raimes J.T. Lau A et al. prospective randomized trail comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer Ann Surg 220 1994 176-182
204. J.J. Bonenkamp I. Songun J. Hermans M. Sasako K. Welvaart J.T. Plukker et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients Lancet 345 1995 745-748
205. A. Cuschieri P. Fayers J. Fielding J. Craven J. Bancewicz V. Joypaul et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomized controlled surgical trial The Surgical Cooperative Group. Lancet 347 1996 995-999
206. J.J. Bonenkamp J. Hermans M. Sasako C.J. van de Velde Dutch Gastric Cancer Group Extended lymph-node dissection for gastric cancer N Engl J Med 340 1999 908-914
207. A. Cuschieri S. Weeden J. Fielding J. Bancewicz J. Craven V. et al. Patient survival after D1 and D2 resections for gastric cancer long-term results of the MRC randomized surgical trial. Joypaul Surgical Co-operative Group. Br J Cancer 79 1999 1522-1530
208. J.R. Siewert K. Bottcher H.J. Stein J.D. Roder Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study Ann Surg 228 1998 449-461
209. P. Edwards G.R. Blackshaw W.G. Lewis J.D. Barry M.C. Allison D.R. Jones Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma Br J Cancer 90 2004 1888-1892
210. M.H. Shiu E. Moore M. Sanders A. Huvos B. Freedman J. Goodbold et al. Influences of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis Arch Surg 122 1987 1347-1351
211. F. Pacelli G.B. Doglietto R. Belantone S. Alfieri A. Sgadari F. Crucitti Extensive versus limited lymph node dissection for gastric cancer: A comparative study of 320 patients Br J Surg 80 1993 1153-1156
212. J.W. Smith M.F. Brennan Surgical treatment of gastric cancer. Proximal, mid, and distal stomach Surg Clin North Am 72 1992 381-399
213. Y. Kodera Y. Yamamura Y. Shimizu A. Torii T. Hirai K. et al. Yasui Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma World J Surg 21 1997 622-627
214. N. Matsukura T. Tajiri S. Kato A. Togashi G. Masuda I. Fujita et al. Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy Gastric Cancer 6 2003 100-107
215. K. Saito K. Arai M. Mori R. Kobayashi I. Ohki Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma Gastrointest Endosc 52 2000 27-32
216. P. Koch F. del Valle W.E. Berdel N.A. Willich B. Reers W. Hiddemann et al. Primary gastrointestinal non-Hodgkin's lymphoma: Combined surgical and conservative or conservative management only in localized gastric lymphoma-results of the prospective German Multicenter Study GIT NHL 01/ 92 J Clin Oncol 19 2001 3874-3883
217. P.G. Isaacson J. Spencer Malignant lymphoma of mucosa-associated lymphoid tissue Histopathology 11 1987 445-462
218. S.S. Yoon D.G. Coit C.S. Portlock M.S. Karpeh The diminishing role of surgery in the treatment of gastric lymphoma Ann Surg 240 2004 28-37
219. Y.H. Ko J.J. Han J.H. Noh H.J. Ree Lymph nodes in gastric B-cell lymphoma: Pattern of involvement and early histological changes Histopathology 40 2002 497-504
220. D. de Jong H. Boot P. van Heerde G.A. Hart B.G. Taal Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance Gastroenterology 112 1997 1466-1474
221. P. Lehours A. Ruskone-Fourmestraux A. Lavergne F. Cantet F. Megraud Groupe d'Etude des Lymphomes Digestifs (GELD) for the Federation Francaise de Cancerologie Digestive (FFCD). Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma? Am J Gastroenterol 98 2003 291-295
222. S. Eidt M. Stolte R. Fischer Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas J Clin Pathol 47 1994 436-439
223. P.G. Isaacson Gastric MALT lymphoma: From concept to cure Ann Oncol 10 1999 637-645
224. S. Umehara H. Higashi N. Ohnishi M. Asaka M. Hatakeyama Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma Oncogene 22 2003 8337-8342
225. A. Enno J.L. O'Rourke C.R. Howlett A. Jack M.F. Dixon A. Lee MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma Am J Pathol 147 1995 217-222
226. European Helicobacter pylori study group VIIIth International Workshop on Gastro-duodenal Pathology and Helicobacter pylori. Edinburgh, Scotland, 7-9 July 1995 Gut 37 Suppl 1 1995 A1-A103
227. A. Enno J. O'Rourke S. Braye R. Howlett A. Lee Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice Am J Pathol 152 1998 1625-1632
228. M. Stolte E. Bayerdorffer A. Morgner B. Alpen T. Wundisch C. Thiede et al. Helicobacter and gastric MALT lymphoma Gut 50 Suppl 3 2002 19-24
229. A. Meining M. Stolte R. Hatz N. Lehn S. Miehlke A. et al. Morgner Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases Virchows Arch 431 1997 11-15
230. Y. Qin A. Greiner M.J. Trunk B. Schmausser M.M. Ott H.K. Muller-Hermelink Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma Blood 86 1995 3528-3534
231. M. Du H. Peng N. Singh P.G. Isaacson L. Pan The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma Blood 86 1995 4587-4593
232. A.C. Wotherspoon C. Doglioni T.C. Diss L. Pan A. Moschini M. de Boni et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori Lancet 342 1993 575-577
233. E. Roggero More on cancer vaccine Ann Oncol 10 1999 1-2
234. A. Morgner S. Miehlke W. Fischbach W. Schmitt H. Muller-Hermelink A. Greiner et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection J Clin Oncol 19 2001 2041-2048
235. M. Sackmann A. Morgner B. Rudolph A. Neubauer C. Thiede H. Schultz et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group Gastroenterology 113 1997 1087-1090
236. S. Nakamura T. Matsumoto H. Suekane M. Takeshita K. Hizawa M. Kawasaki et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori Gut 48 2001 454-460
237. H. Liu H. Ye A. Ruskone-Fourmestraux D. De Jong S. Pileri C. Thiede et al. T(11:18) is a marker for all stage gastric MALT lymphomas that will not respond to H pylori eradication Gastroenterology 122 2002 1286-1294
238. S. Alkan D.S. Karcher M.A. Newman P. Cohen Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori Lancet 348 1996 268-269
239. W. Fischbach W. Tacke A. Greiner H. Konrad Muller-Hermelink Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori Lancet 349 1997 31-32
240. T. Matsumoto M. Iida M. Shimizu Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori Lancet 350 1997 115-116
241. C.B. Rosen J.A. van Heerden J.K. Martin Jr L.E. Wold D.M. Ilstrup Is an aggressive surgical approach to the patient with gastric lymphoma warranted? Ann Surg 205 1987 634-640
242. F. Brands S.P. Monig M. Raab Treatment and prognosis of gastric lymphoma Eur J Surg 163 1997 803-813
243. D.L. Bartlett M.S. Karpeh Jr D.A. Filippa M.F. Brennan Long-term follow-up after curative surgery for early gastric lymphoma Ann Surg 223 1996 53-62
244. J. Yahalom MALT lymphomas: A radiation oncology viewpoint Ann Hematol 80 Suppl 3 2001 B100-B105
245. A. Makristathis A.M. Hirschl P. Lehours F. Megraud Diagnosis of Helicobacter pylori infection Helicobacter 9 Suppl 1 2004 7-14
246. M. Matsuda Y. Noda Y. Takemori Novel diagnostic method of testing for Helicobacter pylori infection using the rapid leukocyte strip test, Leukostix J Gastroenterol Hepatol 18 2003 1196-1201
247. S. Kim K. Harum M. Ito S. Tanaka M. Yoshihara K. Chayama Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum Dig Liver Dis 36 2004 286-291
248. S.W. Wang F.J. Yu Y.C. Lo The clinical utility of string-PCR test in diagnosing Helicobacter pylori infection Hepatogastroenterology 50 2003 1208-1213
249. 14C-urea breath test for the diagnosis of Helicobacter pylori infection: Clinical validation and comparison with the standard method Eur J Nucl Med Mol Imaging 30 2003 1457-1462
250. 14C-urea in the detection of the Helicobacter pylori infection Nucl Med Rev Cent East Eur 5 2002 21-24
251. P. Michetti G. Dorta P.H. Wiesel Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La-1 on Helicobacter pylori infection in humans Digestion 60 1999 203-209
252. Y. Aiba N. Suzuki A.M. Kabir A. Takagi Y. Koga Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model Am J Gastroenterol 93 1998 2097-2101
253. T. Mukai T. Asasaka E. Sato K. Mori M. Matsumoto H. Ohori Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri FEMS Immunol Med Microbol 32 2002 105-110
254. F. Canducci A. Armuzzi F. Cremonini G. Cammarota F. Bartolozzi P. Pola et al. VA lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates Aliment Pharmacol Ther 14 2000 1625-1629
255. I. Sakomoto M. Igarashi K. Kimura A. Takagi T. Miwa Y. Koga Suppressive effect of Lactobacillus gasseri OLL 27166 (LG21) on Helicobacter pylori infection in humans J Antimicrob Chemother 47 2001 709-710
256. F. Cremonini S. Di Caro M. Covino Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study Am J Gastroenterol 97 2002 2744-2749
257. J.M. Hamilton-Miller The role of probiotics in the treatment and prevention of Helicobacter pylori infection Int J Antimicrob Agents 22 2003 360-366
258. P. Ruggiero S. Peppoloni R. Rappuoli G. Del Giudice The quest for a vaccine against Helicobacter pylori: How to move from mouse to man? Microbes Infec 5 2003 749-756
259. G. Del Giudice A. Covacci J.L. Telford C. Montecucco R. Rappuoli The design of vaccines against Helicobacter pylori and their development Annu Rev Immunol 19 2001 523-563
260. G. Rossi M. Rossi C.G. Vitali D. Fortuna D. Burroni L. Pancotto et al. A conventional beagle dog model for acute and chronic infection with Helicobacter pylori Infect Immun 67 1999 3112-3120 3120